Status:
COMPLETED
Comparative Effects of Milk Thistle Extract With Vitamin-E in Hemodialysis Patients
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Hemodialysis
End Stage Renal Disease
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
For end-stage renal disease (ESRD) patients, cardiovascular disease remains the single most common cause of excess morbidity and mortality. Among the examined nontraditional risk factors, an increase ...
Eligibility Criteria
Inclusion
- All hemodialysis patients age 18-60
- On hemodialysis for over 3 months, 3 times a week, and for 4 hours each time
- Signed informed consent
Exclusion
- Heart Failure NYHA Class III or IV
- Recent MI (within 1 year)
- Use of anti-oxidant supplements: N-acetyl-cystein, Omega 3, Vit C, Vit E, green tea, soy extracts, pomegranate extract, grape extract..
- Hepatitis B or C
- Active Infection
- Psychiatric illness
- Active malignancy
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01001845
Start Date
June 1 2009
End Date
May 1 2010
Last Update
January 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemazi Hospital
Shiraz, Fars, Iran, 71345